Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The concept of overdiagnosis is a tricky one.
Using artificial intelligence for breast cancer screening may be as effective as standard screening methods.
Study shows nearly a quarter of cancer patients with esophageal adenocarcinoma had normal endoscopic screenings within the year
Part 3 in a series from the University of Colorado that unpacks the goals of the National Cancer Institute’s National Cancer Plan.
A survey by the American Cancer Society Cancer Action Network explores preventive screenings and costs.
The USPSTF’s updated guidance for mammograms is especially important for Black women, who are 40% more likely to die of breast cancer.
Scientists answer the call in a nationwide effort to find out.
WISDOM study expands to women as young as 30
People with pancreatic cancer who are screened yearly are diagnosed earlier and have better health outcomes.
An estimated 9.4 million screening tests that normally would have taken place in the United States in 2020 didn’t happen.
Are the costs of screenings and the potential harms of overdiagnosis justified by the number of lives that could be lost to melanoma?
Community clinics in low-income communities saw a decline in breast cancer screening during the pandemic, new report finds.
Young Black men who received PSA testing more often were 40% less likely to be diagnosed with advanced prostate cancer.
Screening appointments for cervix, colon and breast cancer are down between 86% and 94%.
All people ages 18 to 79 should be screened for hepatitis C virus at least once, regardless of risk factors.
Annual screenings cut mortality rates by 24% in men and 33% in women.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.